Bioasis Technologies Inc.
BIOAF
$0.00
$0.00-66.67%
OTC PK
| 11/30/2022 | 08/31/2022 | 05/31/2022 | 02/28/2022 | 11/30/2021 | |
|---|---|---|---|---|---|
| Net Income | -731.20K | -845.60K | -183.50K | -445.80K | -1.01M |
| Total Depreciation and Amortization | 25.80K | 24.30K | 10.60K | 10.70K | 10.90K |
| Total Amortization of Deferred Charges | 155.70K | 178.60K | 194.00K | 201.50K | 193.80K |
| Total Other Non-Cash Items | 45.40K | 155.80K | -513.50K | -411.80K | 212.30K |
| Change in Net Operating Assets | 175.40K | 313.30K | 29.00K | 110.00K | -157.00K |
| Cash from Operations | -328.80K | -173.50K | -463.30K | -535.40K | -753.10K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | 0.00 | 0.00 |
| Total Debt Repaid | 0.00 | 0.00 | -375.00K | -375.00K | -- |
| Issuance of Common Stock | -- | -- | -- | 196.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 0.00 | 0.00 |
| Cash from Financing | 0.00 | 0.00 | -295.00K | -140.80K | 0.00 |
| Foreign Exchange rate Adjustments | 23.40K | 20.90K | -1.50K | -2.30K | 9.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -305.40K | -152.60K | -759.80K | -678.50K | -744.00K |